• 03 Apr 2017

Morning Note

Avacta Group, 18.2 | Iofina, 24.2 | Renew, 385 | Minds + Machines Group, 6.0

    • finnCap Team

    • 6 pages

Stock Image


 
Stock Image


Avacta* (AVCT): Cash burn lower, immunogencity low – both meaningful positives (CORP) | Iofina* (IOF): Production update (CORP) | Renew (RNWH): High ROCE and strong cash flow (BUY) | Minds + Machines* (MMX): .vip going strong (CORP)

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Avacta Group - Affimer drug conjugates attracting interest

Companies: Avacta Group

Bitesize briefing - Avacta

Companies: Avacta Group

Morning Note – 10 October 2019

Companies: DSCV AVCT CTP EOG MCL

Avacta (AVCT) presentation at ShareSoc London 13th March 2019

Companies: Avacta Group

Minds + Machines Group 'now generating real cash' as business momentum continues

Companies: Minds + Machines Group

Copyright © 2019 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top